世界のバイオシミラー医薬品市場2017

◆英語タイトル:Global Biosimilar Drug Sales Market Report 2017
◆商品コード:QYR70301346
◆発行会社(リサーチ会社):QYResearch
◆発行日:2017年1月26日
◆ページ数:121
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD4,000 ⇒換算¥432,000見積依頼/購入/質問フォーム
Enterprise(全社内共有可)USD8,000 ⇒換算¥864,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

当調査レポートでは、世界のバイオシミラー医薬品市場2017について調査・分析し、バイオシミラー医薬品のメーカー別販売量、市場シェア分析、種類別販売分析、用途別販売分析、主要地域別販売分析(米国、中国、欧州、日本、東南アジア、インド)、コスト分析、価格データ、企業情報、バイオシミラー医薬品産業チェーン分析、世界市場規模予測などを含め、以下の構成でお届けいたします。

・バイオシミラー医薬品市場概要
・バイオシミラー医薬品のメーカー別販売量・メーカー別シェア
・バイオシミラー医薬品の世界市場:種類別販売量・市場シェア
・バイオシミラー医薬品の世界市場:用途別販売量・市場シェア
・バイオシミラー医薬品の世界市場:地域別販売量・市場シェア
・バイオシミラー医薬品の米国市場規模
・バイオシミラー医薬品の中国市場規模
・バイオシミラー医薬品の欧州市場規模
・バイオシミラー医薬品の日本市場規模
・バイオシミラー医薬品の東南アジア市場規模
・バイオシミラー医薬品のインド市場規模
・バイオシミラー医薬品のメーカー別分析(企業概要、事業概要、商品概要、収益、価格等)
・バイオシミラー医薬品のコスト分析・価格動向
・バイオシミラー医薬品の産業チェーン(サプライチェーン分析)
・バイオシミラー医薬品のマーケティング戦略・販売チャネル、流通業者
・バイオシミラー医薬品市場への影響要因分析
・バイオシミラー医薬品の世界市場予測
・バイオシミラー医薬品の米国市場予測
・バイオシミラー医薬品の中国市場予測
・バイオシミラー医薬品の欧州市場予測
・バイオシミラー医薬品の日本市場予測
・バイオシミラー医薬品の東南アジア市場予測
・バイオシミラー医薬品のインド市場予測
・バイオシミラー医薬品の種類別世界市場予測
・バイオシミラー医薬品の用途別世界市場予測
...
【レポートの概要】

Notes:Sales, means the sales volume of Biosimilar Drug
Revenue, means the sales value of Biosimilar Drug

This report studies sales (consumption) of Biosimilar Drug in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering
CP Guojian Pharma
Biotech Pharma
Celgen Pharma
Henlius

Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Biosimilar Drug in these regions, from 2011 to 2021 (forecast), like
United States
China
Europe
Japan
Southeast Asia
India
Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type, can be divided into
Injection
Tablets
Others
Split by applications, this report focuses on sales, market share and growth rate of Biosimilar Drug in each application, can be divided into
Ankylosing Spondylitis
Tumor
Rheumatoid Arthrtis
Cardiovascular

【レポートの目次】

Table of Contents

Global Biosimilar Drug Sales Market Report 2017
1 Biosimilar Drug Overview
1.1 Product Overview and Scope of Biosimilar Drug
1.2 Classification of Biosimilar Drug
1.2.1 Injection
1.2.2 Tablets
1.2.3 Others
1.3 Application of Biosimilar Drug
1.3.1 Ankylosing Spondylitis
1.3.2 Tumor
1.3.3 Rheumatoid Arthrtis
1.3.4 Cardiovascular
1.4 Biosimilar Drug Market by Regions
1.4.1 United States Status and Prospect (2012-2022)
1.4.2 China Status and Prospect (2012-2022)
1.4.3 Europe Status and Prospect (2012-2022)
1.4.4 Japan Status and Prospect (2012-2022)
1.4.5 Southeast Asia Status and Prospect (2012-2022)
1.4.6 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value and Volume) of Biosimilar Drug (2012-2022)
1.5.1 Global Biosimilar Drug Sales and Growth Rate (2012-2022)
1.5.2 Global Biosimilar Drug Revenue and Growth Rate (2012-2022)

2 Global Biosimilar Drug Competition by Manufacturers, Type and Application
2.1 Global Biosimilar Drug Market Competition by Manufacturers
2.1.1 Global Biosimilar Drug Sales and Market Share of Key Manufacturers (2012-2017)
2.1.2 Global Biosimilar Drug Revenue and Share by Manufacturers (2012-2017)
2.2 Global Biosimilar Drug (Volume and Value) by Type
2.2.1 Global Biosimilar Drug Sales and Market Share by Type (2012-2017)
2.2.2 Global Biosimilar Drug Revenue and Market Share by Type (2012-2017)
2.3 Global Biosimilar Drug (Volume and Value) by Regions
2.3.1 Global Biosimilar Drug Sales and Market Share by Regions (2012-2017)
2.3.2 Global Biosimilar Drug Revenue and Market Share by Regions (2012-2017)
2.4 Global Biosimilar Drug (Volume) by Application

3 United States Biosimilar Drug (Volume, Value and Sales Price)
3.1 United States Biosimilar Drug Sales and Value (2012-2017)
3.1.1 United States Biosimilar Drug Sales and Growth Rate (2012-2017)
3.1.2 United States Biosimilar Drug Revenue and Growth Rate (2012-2017)
3.1.3 United States Biosimilar Drug Sales Price Trend (2012-2017)
3.2 United States Biosimilar Drug Sales and Market Share by Manufacturers
3.3 United States Biosimilar Drug Sales and Market Share by Type
3.4 United States Biosimilar Drug Sales and Market Share by Application

4 China Biosimilar Drug (Volume, Value and Sales Price)
4.1 China Biosimilar Drug Sales and Value (2012-2017)
4.1.1 China Biosimilar Drug Sales and Growth Rate (2012-2017)
4.1.2 China Biosimilar Drug Revenue and Growth Rate (2012-2017)
4.1.3 China Biosimilar Drug Sales Price Trend (2012-2017)
4.2 China Biosimilar Drug Sales and Market Share by Manufacturers
4.3 China Biosimilar Drug Sales and Market Share by Type
4.4 China Biosimilar Drug Sales and Market Share by Application

5 Europe Biosimilar Drug (Volume, Value and Sales Price)
5.1 Europe Biosimilar Drug Sales and Value (2012-2017)
5.1.1 Europe Biosimilar Drug Sales and Growth Rate (2012-2017)
5.1.2 Europe Biosimilar Drug Revenue and Growth Rate (2012-2017)
5.1.3 Europe Biosimilar Drug Sales Price Trend (2012-2017)
5.2 Europe Biosimilar Drug Sales and Market Share by Manufacturers
5.3 Europe Biosimilar Drug Sales and Market Share by Type
5.4 Europe Biosimilar Drug Sales and Market Share by Application

6 Japan Biosimilar Drug (Volume, Value and Sales Price)
6.1 Japan Biosimilar Drug Sales and Value (2012-2017)
6.1.1 Japan Biosimilar Drug Sales and Growth Rate (2012-2017)
6.1.2 Japan Biosimilar Drug Revenue and Growth Rate (2012-2017)
6.1.3 Japan Biosimilar Drug Sales Price Trend (2012-2017)
6.2 Japan Biosimilar Drug Sales and Market Share by Manufacturers
6.3 Japan Biosimilar Drug Sales and Market Share by Type
6.4 Japan Biosimilar Drug Sales and Market Share by Application
7 Southeast Asia Biosimilar Drug (Volume, Value and Sales Price)
7.1 Southeast Asia Biosimilar Drug Sales and Value (2012-2017)
7.1.1 Southeast Asia Biosimilar Drug Sales and Growth Rate (2012-2017)
7.1.2 Southeast Asia Biosimilar Drug Revenue and Growth Rate (2012-2017)
7.1.3 Southeast Asia Biosimilar Drug Sales Price Trend (2012-2017)
7.2 Southeast Asia Biosimilar Drug Sales and Market Share by Manufacturers
7.3 Southeast Asia Biosimilar Drug Sales and Market Share by Type
7.4 Southeast Asia Biosimilar Drug Sales and Market Share by Application
8 India Biosimilar Drug (Volume, Value and Sales Price)
8.1 India Biosimilar Drug Sales and Value (2012-2017)
8.1.1 India Biosimilar Drug Sales and Growth Rate (2012-2017)
8.1.2 India Biosimilar Drug Revenue and Growth Rate (2012-2017)
8.1.3 India Biosimilar Drug Sales Price Trend (2012-2017)
8.2 India Biosimilar Drug Sales and Market Share by Manufacturers
8.3 India Biosimilar Drug Sales and Market Share by Type
8.4 India Biosimilar Drug Sales and Market Share by Application

9 Global Biosimilar Drug Manufacturers Analysis
9.1 CP Guojian Pharma
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Biosimilar Drug Product Type, Application and Specification
9.1.2.1 Product A
9.1.2.2 Product B
9.1.3 CP Guojian Pharma Biosimilar Drug Sales, Revenue, Price and Gross Margin (2012-2017)
9.1.4 Main Business/Business Overview
9.2 Biotech Pharma
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Biosimilar Drug Product Type, Application and Specification
9.2.2.1 Product A
9.2.2.2 Product B
9.2.3 Biotech Pharma Biosimilar Drug Sales, Revenue, Price and Gross Margin (2012-2017)
9.2.4 Main Business/Business Overview
9.3 Celgen Pharma
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Biosimilar Drug Product Type, Application and Specification
9.3.2.1 Product A
9.3.2.2 Product B
9.3.3 Celgen Pharma Biosimilar Drug Sales, Revenue, Price and Gross Margin (2012-2017)
9.3.4 Main Business/Business Overview
9.4 Henlius
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Biosimilar Drug Product Type, Application and Specification
9.4.2.1 Product A
9.4.2.2 Product B
9.4.3 Henlius Biosimilar Drug Sales, Revenue, Price and Gross Margin (2012-2017)
9.4.4 Main Business/Business Overview

10 Biosimilar Drug Maufacturing Cost Analysis
10.1 Biosimilar Drug Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Biosimilar Drug
10.3 Manufacturing Process Analysis of Biosimilar Drug

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Biosimilar Drug Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Biosimilar Drug Major Manufacturers in 2015
11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 Global Biosimilar Drug Market Forecast (2017-2022)
14.1 Global Biosimilar Drug Sales, Revenue and Price Forecast (2017-2022)
14.1.1 Global Biosimilar Drug Sales and Growth Rate Forecast (2017-2022)
14.1.2 Global Biosimilar Drug Revenue and Growth Rate Forecast (2017-2022)
14.1.3 Global Biosimilar Drug Price and Trend Forecast (2017-2022)
14.2 Global Biosimilar Drug Sales, Revenue and Growth Rate Forecast by Regions (2017-2022)
14.2.1 United States Biosimilar Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.2 China Biosimilar Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.3 Europe Biosimilar Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.4 Japan Biosimilar Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.5 Southeast Asia Biosimilar Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.6 India Biosimilar Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
14.3 Global Biosimilar Drug Sales, Revenue and Price Forecast by Type (2017-2022)
14.4 Global Biosimilar Drug Sales Forecast by Application (2017-2022)

15 Research Findings and Conclusion

16 Appendix
Methodology
Analyst Introduction
Data Source

List of Tables and Figures

Figure Picture of Biosimilar Drug
Table Classification of Biosimilar Drug
Figure Global Sales Market Share of Biosimilar Drug by Type in 2015
Figure Injection Picture
Figure Tablets Picture
Figure Others Picture
Table Applications of Biosimilar Drug
Figure Global Sales Market Share of Biosimilar Drug by Application in 2015
Figure Ankylosing Spondylitis Examples
Figure Tumor Examples
Figure Rheumatoid Arthrtis Examples
Figure Cardiovascular Examples
Figure United States Biosimilar Drug Revenue and Growth Rate (2012-2022)
Figure China Biosimilar Drug Revenue and Growth Rate (2012-2022)
Figure Europe Biosimilar Drug Revenue and Growth Rate (2012-2022)
Figure Japan Biosimilar Drug Revenue and Growth Rate (2012-2022)
Figure Southeast Asia Biosimilar Drug Revenue and Growth Rate (2012-2022)
Figure India Biosimilar Drug Revenue and Growth Rate (2012-2022)
Figure Global Biosimilar Drug Sales and Growth Rate (2012-2022)
Figure Global Biosimilar Drug Revenue and Growth Rate (2012-2022)
Table Global Biosimilar Drug Sales of Key Manufacturers (2012-2017)
Table Global Biosimilar Drug Sales Share by Manufacturers (2012-2017)
Figure 2015 Biosimilar Drug Sales Share by Manufacturers
Figure 2016 Biosimilar Drug Sales Share by Manufacturers
Table Global Biosimilar Drug Revenue by Manufacturers (2012-2017)
Table Global Biosimilar Drug Revenue Share by Manufacturers (2012-2017)
Table 2015 Global Biosimilar Drug Revenue Share by Manufacturers
Table 2016 Global Biosimilar Drug Revenue Share by Manufacturers
Table Global Biosimilar Drug Sales and Market Share by Type (2012-2017)
Table Global Biosimilar Drug Sales Share by Type (2012-2017)
Figure Sales Market Share of Biosimilar Drug by Type (2012-2017)
Figure Global Biosimilar Drug Sales Growth Rate by Type (2012-2017)
Table Global Biosimilar Drug Revenue and Market Share by Type (2012-2017)
Table Global Biosimilar Drug Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Biosimilar Drug by Type (2012-2017)
Figure Global Biosimilar Drug Revenue Growth Rate by Type (2012-2017)
Table Global Biosimilar Drug Sales and Market Share by Regions (2012-2017)
Table Global Biosimilar Drug Sales Share by Regions (2012-2017)
Figure Sales Market Share of Biosimilar Drug by Regions (2012-2017)
Figure Global Biosimilar Drug Sales Growth Rate by Regions (2012-2017)
Table Global Biosimilar Drug Revenue and Market Share by Regions (2012-2017)
Table Global Biosimilar Drug Revenue Share by Regions (2012-2017)
Figure Revenue Market Share of Biosimilar Drug by Regions (2012-2017)
Figure Global Biosimilar Drug Revenue Growth Rate by Regions (2012-2017)
Table Global Biosimilar Drug Sales and Market Share by Application (2012-2017)
Table Global Biosimilar Drug Sales Share by Application (2012-2017)
Figure Sales Market Share of Biosimilar Drug by Application (2012-2017)
Figure Global Biosimilar Drug Sales Growth Rate by Application (2012-2017)
Figure United States Biosimilar Drug Sales and Growth Rate (2012-2017)
Figure United States Biosimilar Drug Revenue and Growth Rate (2012-2017)
Figure United States Biosimilar Drug Sales Price Trend (2012-2017)
Table United States Biosimilar Drug Sales by Manufacturers (2012-2017)
Table United States Biosimilar Drug Market Share by Manufacturers (2012-2017)
Table United States Biosimilar Drug Sales by Type (2012-2017)
Table United States Biosimilar Drug Market Share by Type (2012-2017)
Table United States Biosimilar Drug Sales by Application (2012-2017)
Table United States Biosimilar Drug Market Share by Application (2012-2017)
Figure China Biosimilar Drug Sales and Growth Rate (2012-2017)
Figure China Biosimilar Drug Revenue and Growth Rate (2012-2017)
Figure China Biosimilar Drug Sales Price Trend (2012-2017)
Table China Biosimilar Drug Sales by Manufacturers (2012-2017)
Table China Biosimilar Drug Market Share by Manufacturers (2012-2017)
Table China Biosimilar Drug Sales by Type (2012-2017)
Table China Biosimilar Drug Market Share by Type (2012-2017)
Table China Biosimilar Drug Sales by Application (2012-2017)
Table China Biosimilar Drug Market Share by Application (2012-2017)
Figure Europe Biosimilar Drug Sales and Growth Rate (2012-2017)
Figure Europe Biosimilar Drug Revenue and Growth Rate (2012-2017)
Figure Europe Biosimilar Drug Sales Price Trend (2012-2017)
Table Europe Biosimilar Drug Sales by Manufacturers (2012-2017)
Table Europe Biosimilar Drug Market Share by Manufacturers (2012-2017)
Table Europe Biosimilar Drug Sales by Type (2012-2017)
Table Europe Biosimilar Drug Market Share by Type (2012-2017)
Table Europe Biosimilar Drug Sales by Application (2012-2017)
Table Europe Biosimilar Drug Market Share by Application (2012-2017)
Figure Japan Biosimilar Drug Sales and Growth Rate (2012-2017)
Figure Japan Biosimilar Drug Revenue and Growth Rate (2012-2017)
Figure Japan Biosimilar Drug Sales Price Trend (2012-2017)
Table Japan Biosimilar Drug Sales by Manufacturers (2012-2017)
Table Japan Biosimilar Drug Market Share by Manufacturers (2012-2017)
Table Japan Biosimilar Drug Sales by Type (2012-2017)
Table Japan Biosimilar Drug Market Share by Type (2012-2017)
Table Japan Biosimilar Drug Sales by Application (2012-2017)
Table Japan Biosimilar Drug Market Share by Application (2012-2017)
Figure Southeast Asia Biosimilar Drug Sales and Growth Rate (2012-2017)
Figure Southeast Asia Biosimilar Drug Revenue and Growth Rate (2012-2017)
Figure Southeast Asia Biosimilar Drug Sales Price Trend (2012-2017)
Table Southeast Asia Biosimilar Drug Sales by Manufacturers (2012-2017)
Table Southeast Asia Biosimilar Drug Market Share by Manufacturers (2012-2017)
Table Southeast Asia Biosimilar Drug Sales by Type (2012-2017)
Table Southeast Asia Biosimilar Drug Market Share by Type (2012-2017)
Table Southeast Asia Biosimilar Drug Sales by Application (2012-2017)
Table Southeast Asia Biosimilar Drug Market Share by Application (2012-2017)
Figure India Biosimilar Drug Sales and Growth Rate (2012-2017)
Figure India Biosimilar Drug Revenue and Growth Rate (2012-2017)
Figure India Biosimilar Drug Sales Price Trend (2012-2017)
Table India Biosimilar Drug Sales by Manufacturers (2012-2017)
Table India Biosimilar Drug Market Share by Manufacturers (2012-2017)
Table India Biosimilar Drug Sales by Type (2012-2017)
Table India Biosimilar Drug Market Share by Type (2012-2017)
Table India Biosimilar Drug Sales by Application (2012-2017)
Table India Biosimilar Drug Market Share by Application (2012-2017)
Table CP Guojian Pharma Basic Information List
Table CP Guojian Pharma Biosimilar Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure CP Guojian Pharma Biosimilar Drug Global Market Share (2012-2017)
Table Biotech Pharma Basic Information List
Table Biotech Pharma Biosimilar Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Biotech Pharma Biosimilar Drug Global Market Share (2012-2017)
Table Celgen Pharma Basic Information List
Table Celgen Pharma Biosimilar Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Celgen Pharma Biosimilar Drug Global Market Share (2012-2017)
Table Henlius Basic Information List
Table Henlius Biosimilar Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Henlius Biosimilar Drug Global Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Biosimilar Drug
Figure Manufacturing Process Analysis of Biosimilar Drug
Figure Biosimilar Drug Industrial Chain Analysis
Table Raw Materials Sources of Biosimilar Drug Major Manufacturers in 2015
Table Major Buyers of Biosimilar Drug
Table Distributors/Traders List
Figure Global Biosimilar Drug Sales and Growth Rate Forecast (2017-2022)
Figure Global Biosimilar Drug Revenue and Growth Rate Forecast (2017-2022)
Table Global Biosimilar Drug Sales Forecast by Regions (2017-2022)
Table Global Biosimilar Drug Sales Forecast by Type (2017-2022)
Table Global Biosimilar Drug Sales Forecast by Application (2017-2022)



【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のバイオシミラー医薬品市場2017(Global Biosimilar Drug Sales Market Report 2017)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆